Search For "serum institute of india"
DCGI's SEC to review applications of Bharat Biotech, SII for full market a
Updated : 4 years, 6 months ago IST
New Delhi [India], January 14 (ANI): Drugs Controller General of India (DCGI)'s Subject Expert Committee will review applications of Bharat Biotech and Serum Institute of India (SII) for full market approval to Covaxin and Covishield respectively on Friday, sources said.
Read More
Novavax, Serum Institute file for emergency use authorisation of Novavax'
Updated : 4 years, 6 months ago IST
Gaithersburg [US], January 10 (ANI): Novavax, a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India (SII), on Monday, announced a regulatory submission to the South African Health Products Re
Read More
Covovax authorisation is a vital step in India, where additional vaccine o
Updated : 4 years, 6 months ago IST
Gaithersburg/Pune (Maryland/Maharashtra)[US/India], December 29 (ANI): Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India (SII), the world's largest vaccin
Read More
SII thanks Centre for granting emergency use nod for COVID-19 vaccine Cov
Updated : 4 years, 6 months ago IST
Pune (Maharashtra) [India], December 28 (ANI): Serum Institute of India on Tuesday expressed gratitude to the Union Health Ministry for granting Emergency Use Authorization for its COVID-19 vaccine Covovax.
Read More
SEC recommends emergency use authorization of Covovax, Corbevax vaccines f
Updated : 4 years, 6 months ago IST
New Delhi [India], December 28 (ANI): After reviewing all applications and data, the Subject Expert Committee (SEC), a body under India's drug regulator, has recommended granting the Emergency Use Authorization (EUA) to Serum Institute of India's COVID-19 vaccine Covovax and Corbevax vacc
Read More
Yet another milestone in fight against COVID-19: Adar Poonawalla on Covova
Updated : 4 years, 7 months ago IST
New Delhi [India], December 17 (ANI): After the Covovax vaccine got WHO's approval for emergency use, Chief Executive Officer of the Serum Institute of India Adar Poonawalla on Friday said that this is yet another milestone in our fight against COVID-19.
Read More
WHO approves emergency use of COVID-19 vaccine Covovax
Updated : 4 years, 7 months ago IST
Geneva [Switzerland], December 17 (ANI): The World Health Organization (WHO) said it had approved the Covovax coronavirus vaccine, which is manufactured by the Serum Institute of India under license from US company Novavax, for emergency use.
Read More
Serum Institute working to develop COVID vaccine booster shot which is mor
Updated : 4 years, 7 months ago IST
New Delhi [India], December 14 (ANI): Chief Executive Officer of the Serum Institute of India Adar Poonawalla on Tuesday said that they are working towards developing a vaccine booster shot which is more effective against Omicron virus.
Read More
Serum Institute's executive director Suresh Jadhav passes away
Updated : 4 years, 7 months ago IST
Pune (Maharashtra) [India], December 9 (ANI): Serum Institute of India (SII) executive director Suresh Jadhav, who played an instrumental role in the field of vaccine manufacturing in India, passed away on Wednesday.
Read More
SII seeks approval for Covishield vaccine as booster dose amid Omicron var
Updated : 4 years, 7 months ago IST
New Delhi [India], December 2 (ANI): The Serum Institute of India (SII) has sought India's drug regulator's approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccine in the country, officials informed ANI on Thursday.
Read More
Serum Institute of India resumes exports of COVID-19 vaccine under COVAX p
Updated : 4 years, 7 months ago IST
Pune (Maharashtra) [India], November 26 (ANI): Serum Institute of India (SII) on Friday resumed the exports of its COVID-19 vaccine 'Covishield' to the international COVID vaccine sharing programme COVAX.
Read More
Serum Institute of India to start Covishield supply to COVAX countries
Updated : 4 years, 7 months ago IST
Pune (Maharashtra) [India], November 22 (ANI): The Serum Institute of India (SII) will start COVID-19 vaccines supply to COVAX countries soon, sources said on Monday.
Read More